Tetrous, Inc.
Biotechnology · SHERMAN OAKS, CA
BiotechnologySEC Form D
Tetrous, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 22, 2026, reporting $1,741,024 raised toward a $4,000,000 offering.
Incorporated in Delaware and based in SHERMAN OAKS, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Tetrous, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Bradley E. PattExecutive Officer · Director
- Gunnar AnderssonDirector
- Simon BerryDirector
- John BojanowskiDirector
- Matthew MuscioDirector
- Jan IwanczykDirector
- Frank PhilipsDirector
- Andy CarterDirector
- Nikhil VermaDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised